Editorial comment
Urology
.
2011 Jan;77(1):129-30; author reply 130.
doi: 10.1016/j.urology.2010.07.509.
Author
Joachim Noldus
PMID:
21195831
DOI:
10.1016/j.urology.2010.07.509
No abstract available
Publication types
Comment
Editorial
MeSH terms
Humans
Male
Phosphodiesterase 5 Inhibitors / therapeutic use*
Prostatic Hyperplasia / complications*
Prostatism / drug therapy*
Prostatism / etiology*
Substances
Phosphodiesterase 5 Inhibitors